Johnson Matthey PLC (LON:JMAT – Get Free Report)’s stock price hit a new 52-week low on Friday . The stock traded as low as GBX 1,312 ($16.02) and last traded at GBX 1,312 ($16.02), with a volume of 487292 shares changing hands. The stock had previously closed at GBX 1,340 ($16.36).
Analyst Ratings Changes
A number of brokerages recently issued reports on JMAT. Berenberg Bank dropped their price target on shares of Johnson Matthey from GBX 1,650 ($20.15) to GBX 1,500 ($18.32) and set a “hold” rating on the stock in a research note on Thursday, November 28th. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 1,800 ($21.98) target price on shares of Johnson Matthey in a research note on Tuesday, December 17th.
Get Our Latest Research Report on JMAT
Johnson Matthey Stock Performance
Johnson Matthey Cuts Dividend
The business also recently announced a dividend, which will be paid on Tuesday, February 4th. Shareholders of record on Thursday, December 5th will be paid a dividend of GBX 22 ($0.27) per share. This represents a yield of 1.47%. The ex-dividend date is Thursday, December 5th. Johnson Matthey’s dividend payout ratio is currently 13,275.86%.
Insider Activity
In other Johnson Matthey news, insider Stephen Oxley acquired 24 shares of the stock in a transaction dated Wednesday, November 20th. The shares were purchased at an average price of GBX 1,504 ($18.36) per share, for a total transaction of £360.96 ($440.73). Also, insider Liam Condon acquired 27 shares of the company’s stock in a transaction that occurred on Wednesday, October 16th. The stock was acquired at an average cost of GBX 1,505 ($18.38) per share, for a total transaction of £406.35 ($496.15). Insiders have purchased a total of 7,458 shares of company stock valued at $10,024,332 in the last 90 days. 0.61% of the stock is currently owned by insiders.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Recommended Stories
- Five stocks we like better than Johnson Matthey
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Dividend Capture Strategy: What You Need to Know
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.